Mar. 16 at 4:42 PM
$CUPR
Cuprina's "Edge" vs. The Competitors
For Cuprina to succeed, they need to win on two points where the giants are weak:
Price: Larval therapy and collagen from frogs can theoretically be produced cheaper than the high-tech cell products from Organogenesis.
Religious/Cultural factors: Since Cuprina's collagen comes from frogs (and not pigs or cows), it may be easier to market in Muslim countries (the halal aspect), which explains their focus on Saudi Arabia.